Skip to main content

Not investment advice.Read full disclaimer

CANF: Can-Fite BioPharma Ltd. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

2thpctl

Volume

0.01×avg

Market Cap

1.70MUSD

P/E Ratio

-752.4TTM

Div Yield

-ann

Continue with finqOS

Explore Can-Fite BioPharma Ltd.'s financials

Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.

Start Free Trial→Sign In

14-day free trial · No credit card required

Can-Fite BioPharma Ltd.

CANFNew York Stock Exchange American·USD·Closed

Can-Fite BioPharma Ltd.

CANFNew York Stock Exchange American·USD·Closed

$3.16

+1.61%

$3.16

+$0.05 (1.61%)

52W Range

2thpctl

Volume

0.01×avg

Mkt Cap

1.70MUSD

P/E

-752.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings